| Year |
Citation |
Score |
| 2019 |
Allott EH, Ebot EM, Stopsack KH, Gonzalez-Feliciano AG, Markt SC, Wilson KM, Ahearn TU, Gerke TA, Downer MK, Rider JR, Freedland SJ, Lotan TL, Kantoff PW, Platz EA, Loda M, et al. Statin use is associated with lower risk of PTEN-null and lethal prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31754047 DOI: 10.1158/1078-0432.Ccr-19-2853 |
0.313 |
|
| 2019 |
Choudhury PP, Wilcox A, Gao C, Carter B, Husing A, Brook M, Eriksson M, Martin K, Scott C, Shi M, Ahearn T, Jones M, Orr N, Schoemaker M, Czene K, et al. Abstract 962: Validation of breast cancer risk model incorporating classical risk factors and polygenic risk scores in 14 prospective cohort studies in 6 countries Epidemiology. DOI: 10.1158/1538-7445.Sabcs18-962 |
0.305 |
|
| 2019 |
Jung AY, Ahearn TU, Behrens S, Zhang H, Middha P, Schmidt M, Chatterjee N, Garcia-Closas M, Chang-Claude J. Abstract 620: Evaluating multiple tumor markers in a novel analysis of reproductive factors and breast cancer risk Cancer Research. 79: 620-620. DOI: 10.1158/1538-7445.Am2019-620 |
0.319 |
|
| 2018 |
Stopsack KH, Gonzalez-Feliciano AG, Peisch SF, Downer MK, Gage RA, Finn S, Lis RT, Graff RE, Pettersson A, Pernar CH, Loda M, Kantoff PW, Ahearn TU, Mucci LA. A prospective study of aspirin use and prostate cancer risk by TMPRSS2:ERG status. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 30108097 DOI: 10.1158/1055-9965.Epi-18-0510 |
0.326 |
|
| 2018 |
Allott EH, Ebot EM, Gonzalez-Feliciano AG, Markt SC, Wilson KM, Ahearn TU, Gerke TA, Downer MK, Stopsack KH, Rider JR, Freedland SJ, Platz EA, Stampfer MJ, Giovannucci EL, Sweeney CJ, et al. Abstract A015: Molecular tumor profiling to identify mechanisms linking statin use with lower risk of lethal prostate cancer: Results from the Health Professionals Follow-up Study Cancer Research. 78. DOI: 10.1158/1538-7445.Prca2017-A015 |
0.335 |
|
| 2015 |
Tu H, Ahearn TU, Daniel CR, Gonzalez-Feliciano AG, Seabrook ME, Bostick RM. Transforming growth factors and receptor as potential modifiable pre-neoplastic biomarkers of risk for colorectal neoplasms. Molecular Carcinogenesis. 54: 821-30. PMID 24719252 DOI: 10.1002/Mc.22152 |
0.699 |
|
| 2015 |
Tu H, Flanders WD, Ahearn TU, Daniel CR, Gonzalez-Feliciano AG, Long Q, Rutherford RE, Bostick RM. Effects of calcium and vitamin D3 on transforming growth factors in rectal mucosa of sporadic colorectal adenoma patients: a randomized controlled trial. Molecular Carcinogenesis. 54: 270-80. PMID 24166893 DOI: 10.1002/Mc.22096 |
0.804 |
|
| 2015 |
Shen H, Ahearn TU, Bostick RM. Effects of calcium and vitamin D supplementation on crypt morphology in normal colon mucosa: A randomized clinical trial. Molecular Carcinogenesis. 54: 242-7. PMID 24115184 DOI: 10.1002/Mc.22090 |
0.753 |
|
| 2015 |
Tu H, Flanders WD, Ahearn TU, Daniel CR, Gonzalez-Feliciano AG, Long Q, Rutherford RE, Bostick RM. Effects of calcium and vitamin D3 on transforming growth factors in rectal mucosa of sporadic colorectal adenoma patients: A randomized controlled trial Molecular Carcinogenesis. 54: 270-280. DOI: 10.1002/mc.22096 |
0.751 |
|
| 2014 |
Tu H, Ahearn TU, Daniel CR, Gonzalez-Feliciano AG, Seabrook ME, Bostick RM. Transforming growth factors and receptor as potential modifiable pre-neoplastic biomarkers of risk for colorectal neoplasms Molecular Carcinogenesis. DOI: 10.1002/mc.22152 |
0.627 |
|
| 2013 |
Citronberg J, Bostick R, Ahearn T, Turgeon DK, Ruffin MT, Djuric Z, Sen A, Brenner DE, Zick SM. Effects of ginger supplementation on cell-cycle biomarkers in the normal-appearing colonic mucosa of patients at increased risk for colorectal cancer: results from a pilot, randomized, and controlled trial. Cancer Prevention Research (Philadelphia, Pa.). 6: 271-81. PMID 23303903 DOI: 10.1158/1940-6207.Capr-12-0327 |
0.637 |
|
| 2013 |
Shen H, Ahearn T, Lipka S, Bostick RM. Mo1130 Effects of Calcium and Vitamin D Supplementation on Crypt Morphology in Normal Colon Mucosa: A Randomized Clinical Trial Gastroenterology. 144. DOI: 10.1016/S0016-5085(13)62164-2 |
0.711 |
|
| 2012 |
Ahearn TU, Shaukat A, Flanders WD, Rutherford RE, Bostick RM. A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on the APC/β-catenin pathway in the normal mucosa of colorectal adenoma patients. Cancer Prevention Research (Philadelphia, Pa.). 5: 1247-56. PMID 22964475 DOI: 10.1158/1940-6207.Capr-12-0292 |
0.748 |
|
| 2012 |
Ahearn TU, Shaukat A, Flanders WD, Seabrook ME, Bostick RM. Markers of the APC/β-catenin signaling pathway as potential treatable, preneoplastic biomarkers of risk for colorectal neoplasms. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 969-79. PMID 22539608 DOI: 10.1158/1055-9965.Epi-12-0126 |
0.628 |
|
| 2012 |
Chai W, Bostick RM, Ahearn TU, Franke AA, Custer LJ, Cooney RV. Effects of vitamin D3 and calcium supplementation on serum levels of tocopherols, retinol, and specific vitamin D metabolites. Nutrition and Cancer. 64: 57-64. PMID 22149065 DOI: 10.1080/01635581.2012.630552 |
0.714 |
|
| 2012 |
Tu H, Daniel C, Ahearn T, Bostick R, Gonzalez-Feliciano A. Abstract 1675: Effects of calcium and vitamin D on TGFβ and TGFβ1expression in rectal mucosa of sporadic colorectal adenoma patients: A randomized controlled trial Cancer Research. 72: 1675-1675. DOI: 10.1158/1538-7445.Am2012-1675 |
0.801 |
|
| 2011 |
Hopkins MH, Owen J, Ahearn T, Fedirko V, Flanders WD, Jones DP, Bostick RM. Effects of supplemental vitamin D and calcium on biomarkers of inflammation in colorectal adenoma patients: a randomized, controlled clinical trial. Cancer Prevention Research (Philadelphia, Pa.). 4: 1645-54. PMID 21724580 DOI: 10.1158/1940-6207.Capr-11-0105 |
0.76 |
|
| 2011 |
Ahearn TU, McCullough ML, Flanders WD, Long Q, Sidelnikov E, Fedirko V, Daniel CR, Rutherford RE, Shaukat A, Bostick RM. A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on markers of their metabolism in normal mucosa of colorectal adenoma patients. Cancer Research. 71: 413-23. PMID 21084270 DOI: 10.1158/0008-5472.Can-10-1560 |
0.775 |
|
| 2011 |
Ahearn TU, McCullough ML, Flanders W, Fedirko V, Rutherford R, Woodard J, Cohen V, Smith E, Bostick RM. Abstract 842: Differences in supplemental calcium and vitamin D3treatment effects on potential biomarkers of risk for colorectal neoplasms according to calcium receptor and vitamin D receptor expression Cancer Research. 71: 842-842. DOI: 10.1158/1538-7445.Am2011-842 |
0.786 |
|
| 2011 |
Lakkur S, Ahearn T, Bostick R. Abstract 1854: Effects of supplemental antioxidant micronutrients on oxidative DNA damage marker in normal colorectal mucosa: A randomized clinical trial Cancer Research. 71: 1854-1854. DOI: 10.1158/1538-7445.Am2011-1854 |
0.563 |
|
| 2010 |
Owen JR, Ahearn T, Liang B, Fedriko V, Woodard J, Bostick RM. Abstract 2895: Effects of supplemental calcium and vitamin D3on serum growth factors in sporadic colorectal adenoma patients in a randomized clinical trial Cancer Research. 70: 2895-2895. DOI: 10.1158/1538-7445.Am10-2895 |
0.746 |
|
| 2010 |
Ahearn T, McCullough ML, Flanders WD, Long Q, Fung J, Ofori-Addo A, Dawadi S, Bostick RM. Abstract 2890: Effects of calcium and vitamin D on markers of vitamin D metabolism in normal colon mucosa: A randomized clinical trial Cancer Research. 70: 2890-2890. DOI: 10.1158/1538-7445.Am10-2890 |
0.77 |
|
| 2007 |
Chaudry Q, Kong KY, Ahearn TU, Cohen V, Bostick RM, Wang MD. An integrated image quantification system for colorectal cancer risk assessment using quantum dots and molecular profiling 2007 4th Ieee International Symposium On Biomedical Imaging: From Nano to Macro - Proceedings. 1280-1283. DOI: 10.1109/ISBI.2007.357093 |
0.511 |
|
| 2006 |
Bostick RM, Kong KY, Ahearn TU, Chaudry Q, Cohen V, Wang MD. Detecting and quantifying biomarkers of risk for colorectal cancer using quantum dots and novel image analysis algorithms. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 1: 3313-6. PMID 17947019 DOI: 10.1109/IEMBS.2006.259745 |
0.516 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2018 |
Allott E, Noonan E, Gonzalez-Feliciano A, Markt S, Wilson K, Ahearn T, Gerke T, Downer M, Stopsack K, Rider J, Freedland S, Lotan T, Kantoff P, Platz E, Loda M, et al. MP21-01 MOLECULAR TUMOR PROFILING TO IDENTIFY MECHANISMS LINKING STATINS WITH LOWER RISK OF LETHAL PROSTATE CANCER Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.692 |
0.298 |
|
| 2015 |
Ahearn TU, Pettersson A, Ebot EM, Gerke T, Morais CD, Hicks J, Wilson KM, Rider JR, Fiorentino M, Finn S, Giovannucci EL, Loda M, Stampfer MJ, Marzo AMD, Mucci LA, et al. Abstract 939: A prospective investigation of PTEN loss and ERG expression in lethal prostate cancer Epidemiology. 75: 939-939. DOI: 10.1158/1538-7445.Am2015-939 |
0.296 |
|
| 2020 |
Zhang H, Zhao N, Ahearn TU, Wheeler W, García-Closas M, Chatterjee N. A mixed-model approach for powerful testing of genetic associations with cancer risk incorporating tumor characteristics. Biostatistics (Oxford, England). PMID 32112086 DOI: 10.1093/Biostatistics/Kxz065 |
0.296 |
|
| 2017 |
Pernar CH, Ebot EM, Pettersson A, Graff RE, Ahearn TU, Gonzalez-Feliciano AG, Markt SC, Wilson KM, Finn S, Fiorentino M, Giovannucci EL, Mucci LA. Abstract 5317: Association of physical activity with risk of prostate cancer defined byTMPRSS2:ERG Epidemiology. 77: 5317-5317. DOI: 10.1158/1538-7445.Am2017-5317 |
0.288 |
|
| 2015 |
Ahearn T, Pettersson A, Ebot E, Gerke T, Morais CD, Hicks J, Wilson K, Rider J, Fiorentino M, Finn S, Giovannucci E, Loda M, Stampfer M, Marzo AD, Mucci L, et al. Mp6-15 Pten Loss And Erg Expression In Prostate Cancer Survival The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.262 |
0.284 |
|
| 2019 |
Ahearn TU, Derkach A, Yarney J, Addai BW, Awuah B, Brinton L, Chatterjee N, Figueroa JD, Garcia-Closas M. Abstract LB-178: Performance of breast cancer polygenic risk score (PRS) in a Ghanaian population Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-Lb-178 |
0.283 |
|
| 2016 |
Ahearn TU, Tchrakian N, Wilson KM, Lis R, Nuttall E, Sesso HD, Loda M, Giovannucci E, Mucci LA, Finn S, Shui IM. Calcium sensing receptor tumor expression and lethal prostate cancer progression. The Journal of Clinical Endocrinology and Metabolism. jc20161082. PMID 27115058 DOI: 10.1210/jc.2016-1082 |
0.271 |
|
| 2017 |
Ebot E, Isikbay M, Gerke T, Ahearn TU, Kelly RS, Tyekucheva S, Pettersson A, Penney KL, Mucci LA. Abstract 4236: Gene expression profiling of prostate tissue identifies biological pathways associated withTMPRSS2:ERGgene fusion Epidemiology. 77: 4236-4236. DOI: 10.1158/1538-7445.Am2017-4236 |
0.251 |
|
| 2019 |
Ribeiro CF, Bastos DC, Pakula H, Ahearn T, Nascimento J, Clohessy JS, Mucci L, Zanata SM, Zadra G, Loda M. Abstract 3591: Genetic and pharmacological inhibition of fatty acid synthase (FASN) attenuates prostate cancer driven byPtenloss Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-3591 |
0.242 |
|
| 2020 |
Adedokun B, Du Z, Gao G, Ahearn T, Lunetta KL, Zirpoli G, Figueroa J, John EM, Bernstein L, Zheng W, Hu JJ, Ziegler RG, Nyante S, Bandera EV, Ingles SA, et al. Abstract 4613: Cross-ancestry genome-wide association study identifies six new loci for breast cancer in women of African and european ancestry Epidemiology. DOI: 10.1158/1538-7445.Am2020-4613 |
0.23 |
|
| 2019 |
Figlioli G, Bogliolo M, Catucci I, Caleca L, Lasheras SV, Pujol R, Kiiski JI, Muranen TA, Barnes DR, Dennis J, Michailidou K, Bolla MK, Leslie G, Aalfs CM, ... ... Ahearn T, et al. The :p.Arg658* truncating variant is associated with risk of triple-negative breast cancer. Npj Breast Cancer. 5: 38. PMID 31700994 DOI: 10.1038/s41523-019-0127-5 |
0.219 |
|
| 2019 |
Dörk T, Peterlongo P, Mannermaa A, Bolla MK, Wang Q, Dennis J, Ahearn T, Andrulis IL, Anton-Culver H, Arndt V, Aronson KJ, Augustinsson A, Freeman LEB, Beckmann MW, Beeghly-Fadiel A, et al. Two truncating variants in FANCC and breast cancer risk. Scientific Reports. 9: 12524. PMID 31467304 DOI: 10.1038/s41598-019-48804-y |
0.212 |
|
| 2014 |
Griglione N, Yarandi S, Srinivasan J, Ahearn T, Dhere T. A comparison of abdominal surgical outcomes between African-American and Caucasian Crohn's patients. International Journal of Colorectal Disease. 29: 917-22. PMID 24828990 DOI: 10.1007/S00384-014-1902-2 |
0.208 |
|
| 2020 |
Byrd D, Vogtmann E, Wu Z, Hullings A, Hua X, Ahearn T, Goedert JJ, Shi J, Figueroa J, Brinton L, Garcia-Closas M, Sinha R. Abstract 4638: Associations of fecal microbial profiles with non-malignant breast disease and breast cancer in the Ghana Breast Health Study Epidemiology. DOI: 10.1158/1538-7445.Am2020-4638 |
0.202 |
|
| 2016 |
Graff RE, Pettersson A, Lis RT, Ahearn TU, Markt SC, Wilson KM, Rider JR, Fiorentino M, Finn S, Kenfield SA, Loda M, Giovannucci EL, Rosner B, Mucci LA. Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression. The American Journal of Clinical Nutrition. PMID 26817504 DOI: 10.3945/ajcn.115.118703 |
0.202 |
|
| 2019 |
Machiela MJ, Myers TA, Lyons CJ, Koster R, Figg WD, Colli LM, Jessop L, Ahearn TU, Freedman ND, García-Closas M, Chanock SJ. Detectible mosaic truncating PPM1D mutations, age and breast cancer risk. Journal of Human Genetics. PMID 30850729 DOI: 10.1038/S10038-019-0589-1 |
0.202 |
|
| 2018 |
Ahearn TU, Peisch S, Pettersson A, Ebot EM, Zhou K, Graff RE, Sinnott JA, Fazli L, Judson GL, Bismar TA, Rider JR, Gerke T, Chan JM, Fiorentino M, Flavin R, et al. Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease. Carcinogenesis. PMID 30165429 DOI: 10.1093/Carcin/Bgy112 |
0.201 |
|
| 2020 |
Kapoor PM, Mavaddat N, Choudhury PP, Wilcox AN, Lindström S, Behrens S, Michailidou K, Dennis J, Bolla MK, Wang Q, Jung A, Abu-Ful Z, Ahearn T, Andrulis IL, Anton-Culver H, et al. Combined associations of a polygenic risk score and classical risk factors with breast cancer risk. Journal of the National Cancer Institute. PMID 32359158 DOI: 10.1093/Jnci/Djaa056 |
0.189 |
|
| 2017 |
Graff RE, Judson G, Ahearn TU, Fiorentino M, Loda M, Giovannucci EL, Mucci LA, Pettersson A. Circulating antioxidant levels and risk of prostate cancer by TMPRSS2:ERG. The Prostate. PMID 28102015 DOI: 10.1002/pros.23312 |
0.189 |
|
| 2023 |
Figlioli G, Billaud A, Ahearn TU, Antonenkova NN, Becher H, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Blok MJ, Bogdanova NV, Bonanni B, Burwinkel B, Camp NJ, Campbell A, et al. FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women. European Journal of Human Genetics : Ejhg. PMID 36707629 DOI: 10.1038/s41431-022-01257-w |
0.188 |
|
| 2020 |
Liu J, Prager-van der Smissen WJC, Collée JM, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Arnold N, et al. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk. Scientific Reports. 10: 9688. PMID 32546843 DOI: 10.1038/S41598-020-65665-Y |
0.188 |
|
| 2015 |
Mehra R, Udager AM, Ahearn TU, Cao X, Feng FY, Loda M, Petimar JS, Kantoff P, Mucci LA, Chinnaiyan AM. Overexpression of the Long Non-coding RNA SChLAP1 Independently Predicts Lethal Prostate Cancer. European Urology. PMID 26724257 DOI: 10.1016/J.Eururo.2015.12.003 |
0.18 |
|
| 2023 |
Olivos N, Banta JE, Spencer-Hwang R, Ansong D, Beane Freeman LE, Clegg-Lamptey JN, Wiafe-Addai B, Edusei L, Adjei E, Titiloye N, Dedey F, Aitpillah F, Oppong J, Vanderpuye V, Osei-Bonsu E, ... Ahearn TU, et al. Mosquito control exposures and breast cancer risk: analysis of 1071 cases and 2096 controls from the Ghana Breast Health Study. Breast Cancer Research : Bcr. 25: 150. PMID 38082317 DOI: 10.1186/s13058-023-01737-x |
0.175 |
|
| 2021 |
Baxter JS, Johnson N, Tomczyk K, Gillespie A, Maguire S, Brough R, Fachal L, Michailidou K, Bolla MK, Wang Q, Dennis J, Ahearn TU, Andrulis IL, Anton-Culver H, Antonenkova NN, et al. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element. American Journal of Human Genetics. PMID 34146516 DOI: 10.1016/j.ajhg.2021.05.013 |
0.174 |
|
| 2020 |
Zhang H, Ahearn TU, Lecarpentier J, Barnes D, Beesley J, Qi G, Jiang X, O'Mara TA, Zhao N, Bolla MK, Dunning AM, Dennis J, Wang Q, Ful ZA, Aittomäki K, et al. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. Nature Genetics. PMID 32424353 DOI: 10.1038/s41588-020-0609-2 |
0.173 |
|
| 2018 |
Pernar CH, Ebot EM, Pettersson A, Graff RE, Giunchi F, Ahearn TU, Gonzalez-Feliciano AG, Markt SC, Wilson KM, Stopsack KH, Gazeeva E, Lis RT, Parmigiani G, Rimm EB, Finn SP, et al. A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERG. European Urology. PMID 30301696 DOI: 10.1016/j.eururo.2018.09.041 |
0.171 |
|
| 2022 |
Dixon-Suen SC, Lewis SJ, Martin RM, English DR, Boyle T, Giles GG, Michailidou K, Bolla MK, Wang Q, Dennis J, Lush M, Investigators A, Ahearn TU, Ambrosone CB, Andrulis IL, et al. Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study. British Journal of Sports Medicine. 56: 1157-1170. PMID 36328784 DOI: 10.1136/bjsports-2021-105132 |
0.168 |
|
| 2020 |
Figueroa JD, Davis Lynn BC, Edusei L, Titiloye N, Adjei E, Clegg-Lamptey JN, Yarney J, Wiafe-Addai B, Awuah B, Duggan MA, Wiafe S, Nyarko K, Aitpillah F, Ansong D, Hewitt SM, ... Ahearn T, et al. Reproductive Factors and Risk of Breast Cancer by Tumor Subtypes among Ghanaian Women: A Population-based Case-control Study. International Journal of Cancer. PMID 32068253 DOI: 10.1002/ijc.32929 |
0.167 |
|
| 2016 |
Graff RE, Meisner A, Ahearn TU, Fiorentino M, Loda M, Giovannucci EL, Mucci LA, Pettersson A. Pre-diagnostic circulating sex hormone levels and risk of prostate cancer by ERG tumour protein expression. British Journal of Cancer. PMID 26986253 DOI: 10.1038/bjc.2016.61 |
0.166 |
|
| 2022 |
Dennis J, Tyrer JP, Walker LC, Michailidou K, Dorling L, Bolla MK, Wang Q, Ahearn TU, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, Freeman LEB, Beckmann MW, et al. Rare germline copy number variants (CNVs) and breast cancer risk. Communications Biology. 5: 65. PMID 35042965 DOI: 10.1038/s42003-021-02990-6 |
0.165 |
|
| 2017 |
Graff RE, Ahearn TU, Pettersson A, Ebot EM, Gerke T, Penney KL, Wilson KM, Markt SC, Pernar CH, Gonzalez-Feliciano AG, Song M, Lis RT, Schmidt DR, Vander Heiden MG, Fiorentino M, et al. Height, obesity, and the risk of TMPRSS2:ERG-defined prostate cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29167279 DOI: 10.1158/1055-9965.EPI-17-0547 |
0.16 |
|
| 2023 |
Morra A, Mavaddat N, Muranen TA, Ahearn TU, Allen J, Andrulis IL, Auvinen P, Becher H, Behrens S, Blomqvist C, Bojesen SE, Bolla MK, Brauch H, Camp NJ, Carvalho S, et al. The impact of coding germline variants on contralateral breast cancer risk and survival. American Journal of Human Genetics. PMID 36827971 DOI: 10.1016/j.ajhg.2023.02.003 |
0.16 |
|
| 2018 |
Mavaddat N, Michailidou K, Dennis J, Lush M, Fachal L, Lee A, Tyrer JP, Chen TH, Wang Q, Bolla MK, Yang X, Adank MA, Ahearn T, Aittomäki K, Allen J, et al. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. American Journal of Human Genetics. PMID 30554720 DOI: 10.1016/J.Ajhg.2018.11.002 |
0.157 |
|
| 2019 |
Choudhury PP, Wilcox AN, Brook MN, Zhang Y, Ahearn T, Orr N, Coulson P, Schoemaker MJ, Jones ME, Gail MH, Swerdlow AJ, Chatterjee N, Garcia-Closas M. Comparative validation of breast cancer risk prediction models and projections for future risk stratification. Journal of the National Cancer Institute. PMID 31165158 DOI: 10.1093/jnci/djz113 |
0.157 |
|
| 2021 |
Johnson N, Maguire S, Morra A, Kapoor PM, Tomczyk K, Jones ME, Schoemaker MJ, Gilham C, Bolla MK, Wang Q, Dennis J, Ahearn TU, Andrulis IL, Anton-Culver H, Antonenkova NN, et al. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers. British Journal of Cancer. PMID 33495599 DOI: 10.1038/s41416-020-01185-w |
0.156 |
|
| 2016 |
Ahearn TU, Pettersson A, Ebot EM, Gerke T, Graff RE, Morais CL, Hicks JL, Wilson KM, Rider JR, Sesso HD, Fiorentino M, Flavin R, Finn S, Giovannucci EL, Loda M, et al. A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer. Journal of the National Cancer Institute. 108. PMID 26615022 DOI: 10.1093/jnci/djv346 |
0.155 |
|
| 2021 |
Adedokun B, Du Z, Gao G, Ahearn TU, Lunetta KL, Zirpoli G, Figueroa J, John EM, Bernstein L, Zheng W, Hu JJ, Ziegler RG, Nyante S, Bandera EV, Ingles SA, et al. Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women. Nature Communications. 12: 4198. PMID 34234117 DOI: 10.1038/s41467-021-24327-x |
0.155 |
|
| 2022 |
Jung AY, Ahearn TU, Behrens S, Middha P, Bolla MK, Wang Q, Arndt V, Aronson KJ, Augustinsson A, Beane Freeman LE, Becher H, Brenner H, Canzian F, Carey LA, Czene K, et al. Distinct reproductive risk profiles for intrinsic-like breast cancer subtypes: pooled analysis of population-based studies. Journal of the National Cancer Institute. PMID 35723569 DOI: 10.1093/jnci/djac117 |
0.154 |
|
| 2022 |
Wang X, Kapoor PM, Auer PL, Dennis J, Dunning AM, Wang Q, Lush M, Michailidou K, Bolla MK, Aronson KJ, Murphy RA, Brooks-Wilson A, Lee DG, Cordina-Duverger E, Guénel P, ... ... Ahearn TU, et al. Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women. Scientific Reports. 12: 6199. PMID 35418701 DOI: 10.1038/s41598-022-10121-2 |
0.151 |
|
| 2022 |
Dorling L, Carvalho S, Allen J, Parsons MT, Fortuno C, González-Neira A, Heijl SM, Adank MA, Ahearn TU, Andrulis IL, Auvinen P, Becher H, Beckmann MW, Behrens S, Bermisheva M, et al. Breast cancer risks associated with missense variants in breast cancer susceptibility genes. Genome Medicine. 14: 51. PMID 35585550 DOI: 10.1186/s13073-022-01052-8 |
0.149 |
|
| 2018 |
Barber LE, Gerke T, Markt SC, Peisch SF, Wilson KM, Ahearn TU, Giovannucci EL, Parmigiani G, Mucci LA. Family history of breast or prostate cancer and prostate cancer risk. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30082473 DOI: 10.1158/1078-0432.CCR-18-0370 |
0.143 |
|
| 2024 |
Yiangou K, Mavaddat N, Dennis J, Zanti M, Wang Q, Bolla MK, Abubakar M, Ahearn TU, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, Augustinsson A, Baten A, et al. Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction. Medrxiv : the Preprint Server For Health Sciences. PMID 38410445 DOI: 10.1101/2024.02.12.24302043 |
0.14 |
|
| 2023 |
Figlioli G, Billaud A, Wang Q, Bolla MK, Dennis J, Lush M, Kvist A, Adank MA, Ahearn TU, Antonenkova NN, Auvinen P, Behrens S, Bermisheva M, Bogdanova NV, Bojesen SE, et al. Spectrum and Frequency of Germline Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases. Cancers. 15. PMID 37444426 DOI: 10.3390/cancers15133313 |
0.14 |
|
| 2023 |
Middha P, Wang X, Behrens S, Bolla MK, Wang Q, Dennis J, Michailidou K, Ahearn TU, Andrulis IL, Anton-Culver H, Arndt V, Aronson KJ, Auer PL, Augustinsson A, Baert T, et al. A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry. Breast Cancer Research : Bcr. 25: 93. PMID 37559094 DOI: 10.1186/s13058-023-01691-8 |
0.14 |
|
| 2022 |
Mavaddat N, Dorling L, Carvalho S, Allen J, González-Neira A, Keeman R, Bolla MK, Dennis J, Wang Q, Ahearn TU, Andrulis IL, Beckmann MW, Behrens S, Benitez J, et al. Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes. Jama Oncology. PMID 35084436 DOI: 10.1001/jamaoncol.2021.6744 |
0.14 |
|
| 2021 |
Dorling L, Carvalho S, Allen J, González-Neira A, Luccarini C, Wahlström C, Pooley KA, Parsons MT, Fortuno C, Wang Q, Bolla MK, Dennis J, Keeman R, Alonso MR, ... ... Ahearn T, et al. Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women. The New England Journal of Medicine. PMID 33471991 DOI: 10.1056/NEJMoa1913948 |
0.139 |
|
| 2022 |
Gao G, Zhao F, Ahearn TU, Lunetta KL, Troester MA, Du Z, Ogundiran TO, Ojengbede O, Blot W, Nathanson KL, Domchek SM, Nemesure B, Hennis A, Ambs S, McClellan J, et al. Polygenic Risk Scores for Prediction of Breast Cancer Risk in Women of African Ancestry: a Cross-Ancestry Approach. Human Molecular Genetics. PMID 35554533 DOI: 10.1093/hmg/ddac102 |
0.138 |
|
| 2019 |
Hashim D, Gonzalez-Feliciano AG, Ahearn TU, Pettersson A, Barber L, Pernar CH, Ebot EM, Isikbay M, Finn SP, Giovannucci EL, Lis RT, Loda M, Parmigiani G, Lotan T, Kantoff PW, et al. Family history of prostate cancer and the incidence of ERG- and phosphatase and tensin homolog-defined prostate cancer. International Journal of Cancer. PMID 31318977 DOI: 10.1002/ijc.32577 |
0.137 |
|
| 2023 |
Levi H, Carmi S, Rosset S, Yerushalmi R, Zick A, Yablonski-Peretz T, Wang Q, Bolla MK, Dennis J, Michailidou K, Lush M, Ahearn T, Andrulis IL, Anton-Culver H, Antoniou AC, et al. Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel. Journal of Medical Genetics. PMID 37451831 DOI: 10.1136/jmg-2023-109185 |
0.133 |
|
| 2017 |
Dickerman BA, Ahearn TU, Giovannucci E, Stampfer MJ, Nguyen PL, Mucci LA, Wilson KM. Weight change, obesity, and risk of prostate cancer progression among men with clinically localized prostate cancer. International Journal of Cancer. PMID 28543830 DOI: 10.1002/ijc.30803 |
0.132 |
|
| 2021 |
Du Z, Gao G, Adedokun B, Ahearn T, Lunetta KL, Zirpoli G, Troester MA, Ruiz-Narváez EA, Haddad SA, Pal Choudhury P, Figueroa J, John EM, Bernstein L, Zheng W, Hu JJ, et al. Evaluating Polygenic Risk Scores for Breast Cancer in Women of African Ancestry. Journal of the National Cancer Institute. PMID 33769540 DOI: 10.1093/jnci/djab050 |
0.13 |
|
| 2021 |
Morra A, Jung AY, Behrens S, Keeman R, Ahearn TU, Anton-Cluver H, Arndt V, Augustinsson A, Auvinen PK, Beane Freeman LE, Becher H, Beckmann MW, Bloomqvist C, Bojesen SE, Bolla MK, et al. Breast cancer risk factors and survival by tumor subtype: pooled analyses from the Breast Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 33500318 DOI: 10.1158/1055-9965.EPI-20-0924 |
0.13 |
|
| 2022 |
Ahearn TU, Zhang H, Michailidou K, Milne RL, Bolla MK, Dennis J, Dunning AM, Lush M, Wang Q, Andrulis IL, Anton-Culver H, Arndt V, Aronson KJ, Auer PL, Augustinsson A, et al. Common variants in breast cancer risk loci predispose to distinct tumor subtypes. Breast Cancer Research : Bcr. 24: 2. PMID 34983606 DOI: 10.1186/s13058-021-01484-x |
0.125 |
|
| 2023 |
Muranen TA, Morra A, Khan S, Barnes DR, Bolla MK, Dennis J, Keeman R, Leslie G, Parsons MT, Wang Q, Ahearn TU, Aittomäki K, Andrulis IL, Arun BK, Behrens S, et al. PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants. Npj Breast Cancer. 9: 37. PMID 37173335 DOI: 10.1038/s41523-023-00546-x |
0.122 |
|
| 2021 |
Ahuno ST, Doebley AL, Ahearn TU, Yarney J, Titiloye N, Hamel N, Adjei E, Clegg-Lamptey JN, Edusei L, Awuah B, Song X, Vanderpuye V, Abubakar M, Duggan M, Stover DG, et al. Circulating tumor DNA is readily detectable among Ghanaian breast cancer patients supporting non-invasive cancer genomic studies in Africa. Npj Precision Oncology. 5: 83. PMID 34535742 DOI: 10.1038/s41698-021-00219-7 |
0.12 |
|
| 2021 |
Chen Z, Guo X, Long J, Ping J, Li B, Fadden MK, Ahearn TU, Stram DO, Shu XO, Jia G, Figueroa J, Palmer JR, Sanderson M, Haiman CA, et al. Discovery of structural deletions in breast cancer predisposition genes using whole genome sequencing data from > 2000 women of African-ancestry. Human Genetics. PMID 34487234 DOI: 10.1007/s00439-021-02342-8 |
0.12 |
|
| 2021 |
Coignard J, Lush M, Beesley J, O'Mara TA, Dennis J, Tyrer JP, Barnes DR, McGuffog L, Leslie G, Bolla MK, Adank MA, Agata S, Ahearn T, Aittomäki K, Andrulis IL, et al. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nature Communications. 12: 1078. PMID 33597508 DOI: 10.1038/s41467-020-20496-3 |
0.119 |
|
| 2023 |
Kentistou KA, Kaisinger LR, Stankovic S, Vaudel M, de Oliveira EM, Messina A, Walters RG, Liu X, Busch AS, Helgason H, Thompson DJ, Santon F, Petricek KM, Zouaghi Y, Huang-Doran I, ... ... Ahearn TU, et al. Understanding the genetic complexity of puberty timing across the allele frequency spectrum. Medrxiv : the Preprint Server For Health Sciences. PMID 37503126 DOI: 10.1101/2023.06.14.23291322 |
0.118 |
|
| 2022 |
Wu Z, Byrd DA, Wan Y, Ansong D, Clegg-Lamptey JN, Wiafe-Addai B, Edusei L, Adjei E, Titiloye N, Dedey F, Aitpillah F, Oppong J, Vanderpuye V, Osei-Bonsu E, Dagnall CL, ... ... Ahearn TU, et al. The oral microbiome and breast cancer and non-malignant breast disease, and its relationship with the fecal microbiome in the Ghana Breast Health Study. International Journal of Cancer. PMID 35657343 DOI: 10.1002/ijc.34145 |
0.118 |
|
| 2021 |
Abubakar M, Zhang J, Ahearn TU, Koka H, Guo C, Lawrence SM, Mutreja K, Figueroa JD, Ying J, Lissowska J, Lyu N, Garcia-Closas M, Yang XR. Tumor-associated Stromal Cellular Density as a Predictor of Recurrence and Mortality in Breast Cancer: Results from Ethnically-diverse Study Populations. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 33952648 DOI: 10.1158/1055-9965.EPI-21-0055 |
0.116 |
|
| 2021 |
Park HA, Neumeyer S, Michailidou K, Bolla MK, Wang Q, Dennis J, Ahearn TU, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, Augustinsson A, Baten A, Beane Freeman LE, et al. Mendelian randomisation study of smoking exposure in relation to breast cancer risk. British Journal of Cancer. PMID 34341517 DOI: 10.1038/s41416-021-01432-8 |
0.115 |
|
| 2021 |
Coignard J, Lush M, Beesley J, O'Mara TA, Dennis J, Tyrer JP, Barnes DR, McGuffog L, Leslie G, Bolla MK, Adank MA, Agata S, Ahearn T, Aittomäki K, Andrulis IL, et al. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nature Communications. 12: 2986. PMID 33990587 DOI: 10.1038/s41467-021-23162-4 |
0.11 |
|
| 2024 |
Ochs-Balcom HM, Preus L, Du Z, Elston RC, Teerlink CC, Jia G, Guo X, Cai Q, Long J, Ping J, Li B, Stram DO, Shu XO, Sanderson M, Gao G, ... Ahearn T, et al. Novel breast cancer susceptibility loci under linkage peaks identified in African ancestry consortia. Human Molecular Genetics. PMID 38263910 DOI: 10.1093/hmg/ddae002 |
0.108 |
|
| 2020 |
Bastos DC, Ribeiro CF, Ahearn T, Nascimento J, Pakula H, Clohessy J, Mucci L, Roberts T, Zanata SM, Zadra G, Loda M. Genetic ablation of FASN attenuates the invasive potential of prostate cancer driven by Pten loss. The Journal of Pathology. PMID 33166087 DOI: 10.1002/path.5587 |
0.106 |
|
| 2021 |
Ruth KS, Day FR, Hussain J, Martínez-Marchal A, Aiken CE, Azad A, Thompson DJ, Knoblochova L, Abe H, Tarry-Adkins JL, Gonzalez JM, Fontanillas P, Claringbould A, Bakker OB, Sulem P, ... ... Ahearn TU, et al. Genetic insights into biological mechanisms governing human ovarian ageing. Nature. PMID 34349265 DOI: 10.1038/s41586-021-03779-7 |
0.106 |
|
| 2014 |
Ahearn TU, Shui IM, Giovannucci EL. The expanding role of body mass in active surveillance for prostate cancer. European Urology. 66: 849-50. PMID 25037639 DOI: 10.1016/j.eururo.2014.06.043 |
0.104 |
|
| 2018 |
Heng YJ, Wang J, Ahearn TU, Brown SB, Zhang X, Ambrosone CB, de Andrade VP, Brufsky AM, Couch FJ, King TA, Modugno F, Vachon CM, DuPre NC, Garcia-Closas M, Troester MA, et al. Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues. Breast Cancer Research and Treatment. PMID 30387004 DOI: 10.1007/S10549-018-5034-1 |
0.104 |
|
| 2023 |
Abubakar M, Ahearn TU, Duggan MA, Lawrence S, Adjei E, Clegg-Lamptey JN, Yarney J, Wiafe-Addai B, Awuah B, Wiafe S, Nyarko K, Aitpillah F, Ansong D, Hewitt SM, Brinton LA, et al. Associations of breast cancer etiologic factors with stromal microenvironment of primary invasive breast cancers in the Ghana Breast Health Study. Research Square. PMID 37090574 DOI: 10.21203/rs.3.rs-2791342/v1 |
0.104 |
|
| 2021 |
Morra A, Escala-Garcia M, Beesley J, Keeman R, Canisius S, Ahearn TU, Andrulis IL, Anton-Culver H, Arndt V, Auer PL, Augustinsson A, Beane Freeman LE, Becher H, Beckmann MW, Behrens S, et al. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment. Breast Cancer Research : Bcr. 23: 86. PMID 34407845 DOI: 10.1186/s13058-021-01450-7 |
0.102 |
|
| 2022 |
Ahearn TU, Pal Choudhury P, Derkach A, Wiafe-Addai B, Awuah B, Yarney J, Edusei L, Titiloye N, Adjei E, Vanderpuye V, Aitpillah F, Dedey F, Oppong J, Osei-Bonsu EB, Duggan MA, et al. Breast cancer risk in women from Ghana carrying rare germline pathogenic mutations. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 35654374 DOI: 10.1158/1055-9965.EPI-21-1397 |
0.101 |
|
| 2023 |
Balasubramanian JB, Choudhury PP, Mukhopadhyay S, Ahearn T, Chatterjee N, García-Closas M, Almeida JS. Wasm-iCARE: a portable and privacy-preserving web module to build, validate, and apply absolute risk models. Arxiv. PMID 37873020 |
0.101 |
|
| 2022 |
Wang X, Chen H, Middha Kapoor P, Su YR, Bolla MK, Dennis J, Dunning AM, Lush M, Wang Q, Michailidou K, Pharoah PDP, Hopper JL, Southey MC, Koutros S, Beane Freeman LE, ... ... Ahearn T, et al. A genome-wide gene-based gene-environment interaction study of breast cancer in more than 90,000 women. Cancer Research Communications. 2: 211-219. PMID 36303815 DOI: 10.1158/2767-9764.CRC-21-0119 |
0.1 |
|
| 2023 |
Wu Z, Pfeiffer RM, Byrd DA, Wan Y, Ansong D, Clegg-Lamptey JN, Wiafe-Addai B, Edusei L, Adjei E, Titiloye N, Dedey F, Aitpillah F, Oppong J, Vanderpuye V, Osei-Bonsu E, ... ... Ahearn TU, et al. Associations of Circulating Estrogens and Estrogen Metabolites with Fecal and Oral Microbiome in Postmenopausal Women in the Ghana Breast Health Study. Microbiology Spectrum. e0157223. PMID 37341612 DOI: 10.1128/spectrum.01572-23 |
0.097 |
|
| 2023 |
Jiang Z, Zhang H, Ahearn TU, Garcia-Closas M, Chatterjee N, Zhu H, Zhan X, Zhao N. The sequence kernel association test for multicategorical outcomes. Genetic Epidemiology. PMID 37078108 DOI: 10.1002/gepi.22527 |
0.096 |
|
| 2022 |
Geczik AM, Falk RT, Xu X, Ansong D, Yarney J, Wiafe-Addai B, Edusei L, Dedey F, Vanderpuye V, Titiloye N, Adjei E, Aitpillah F, Osei-Bonsu E, Oppong J, Biritwum R, ... ... Ahearn TU, et al. Measured body size and serum estrogen metabolism in postmenopausal women: the Ghana Breast Health Study. Breast Cancer Research : Bcr. 24: 9. PMID 35081987 DOI: 10.1186/s13058-022-01500-8 |
0.092 |
|
| 2021 |
Byrd DA, Vogtmann E, Wu Z, Han Y, Wan Y, Clegg-Lamptey JN, Yarney J, Wiafe-Addai B, Wiafe S, Awuah B, Ansong D, Nyarko K, Hullings AG, Hua X, Ahearn T, et al. Associations of fecal microbial profiles with breast cancer and non-malignant breast disease in the Ghana Breast Health Study. International Journal of Cancer. PMID 33460452 DOI: 10.1002/ijc.33473 |
0.092 |
|
| 2023 |
Mueller SH, Lai AG, Valkovskaya M, Michailidou K, Bolla MK, Wang Q, Dennis J, Lush M, Abu-Ful Z, Ahearn TU, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, et al. Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry. Genome Medicine. 15: 7. PMID 36703164 DOI: 10.1186/s13073-022-01152-5 |
0.086 |
|
| 2023 |
Zhang H, Zhan J, Jin J, Zhang J, Lu W, Zhao R, Ahearn TU, Yu Z, O'Connell J, Jiang Y, Chen T, Okuhara D, Garcia-Closas M, Lin X, Koelsch BL, et al. A new method for multiancestry polygenic prediction improves performance across diverse populations. Nature Genetics. PMID 37749244 DOI: 10.1038/s41588-023-01501-z |
0.074 |
|
| 2023 |
García-Closas M, Ahearn TU, Gaudet MM, Hurson AN, Balasubramanian JB, Choudhury PP, Gerlanc NM, Patel B, Russ D, Abubakar M, Freedman ND, Wong WSW, Chanock SJ, de Gonzalez AB, Almeida JS. Moving towards FAIR practices in epidemiological research. American Journal of Epidemiology. PMID 36804665 DOI: 10.1093/aje/kwad040 |
0.027 |
|
| 2022 |
Geczik AM, Falk RT, Xu X, Wiafe-Addai B, Yarney J, Awuah B, Biritwum R, Vanderpuye V, Dedey F, Adjei E, Aitpillah F, Osei-Bonsu E, Oppong J, Titiloye N, Edusei L, ... ... Ahearn TU, et al. Relation of circulating estrogens with hair relaxer and skin lightener use among postmenopausal women in Ghana. Journal of Exposure Science & Environmental Epidemiology. PMID 34992224 DOI: 10.1038/s41370-021-00407-4 |
0.016 |
|
| 2022 |
Geczik AM, Falk RT, Xu X, Wiafe-Addai B, Yarney J, Awuah B, Biritwum R, Vanderpuye V, Dedey F, Adjei E, Aitpillah F, Osei-Bonsu E, Oppong J, Titiloye N, Edusei L, ... ... Ahearn TU, et al. Correction to: Relation of circulating estrogens with hair relaxer and skin lightener use among postmenopausal women in Ghana. Journal of Exposure Science & Environmental Epidemiology. PMID 35094015 DOI: 10.1038/s41370-022-00415-y |
0.01 |
|
| Hide low-probability matches. |